449 related articles for article (PubMed ID: 19172123)
1. Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease.
Joishy M; Davies I; Ahmed M; Wassel J; Davies K; Sayers A; Jenkins H
J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):48-54. PubMed ID: 19172123
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy.
von Roon AC; Karamountzos L; Purkayastha S; Reese GE; Darzi AW; Teare JP; Paraskeva P; Tekkis PP
Am J Gastroenterol; 2007 Apr; 102(4):803-13. PubMed ID: 17324124
[TBL] [Abstract][Full Text] [Related]
4. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
Fagerberg UL; Lööf L; Lindholm J; Hansson LO; Finkel Y
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):414-20. PubMed ID: 18030206
[TBL] [Abstract][Full Text] [Related]
5. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
Kolho KL; Raivio T; Lindahl H; Savilahti E
Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
[TBL] [Abstract][Full Text] [Related]
6. Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease.
Walker TR; Land ML; Kartashov A; Saslowsky TM; Lyerly DM; Boone JH; Rufo PA
J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):414-22. PubMed ID: 17414136
[TBL] [Abstract][Full Text] [Related]
7. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease.
Reinders CA; Jonkers D; Janson EA; Stockbrügger RW; Stobberingh EE; Hellström PM; Lundberg JO
Scand J Gastroenterol; 2007 Oct; 42(10):1151-7. PubMed ID: 17852876
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of four fecal assays in the diagnosis of colitis.
Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F
Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
[TBL] [Abstract][Full Text] [Related]
9. Review of fecal biomarkers in inflammatory bowel disease.
Sutherland AD; Gearry RB; Frizelle FA
Dis Colon Rectum; 2008 Aug; 51(8):1283-91. PubMed ID: 18543035
[TBL] [Abstract][Full Text] [Related]
10. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H
Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166
[TBL] [Abstract][Full Text] [Related]
11. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease.
Lamb CA; Mohiuddin MK; Gicquel J; Neely D; Bergin FG; Hanson JM; Mansfield JC
Br J Surg; 2009 Jun; 96(6):663-74. PubMed ID: 19384912
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice.
Berni Canani R; Rapacciuolo L; Romano MT; Tanturri de Horatio L; Terrin G; Manguso F; Cirillo P; Paparo F; Troncone R
Dig Liver Dis; 2004 Jul; 36(7):467-70. PubMed ID: 15285526
[TBL] [Abstract][Full Text] [Related]
13. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.
Kane SV; Sandborn WJ; Rufo PA; Zholudev A; Boone J; Lyerly D; Camilleri M; Hanauer SB
Am J Gastroenterol; 2003 Jun; 98(6):1309-14. PubMed ID: 12818275
[TBL] [Abstract][Full Text] [Related]
14. [Fecal calprotectin: a diagnostic tool for inflammatory bowel disease].
Fraga M; Godat S; Nydegger A; Moradpour D; Schoepfer AM
Rev Med Suisse; 2012 Sep; 8(352):1669-70, 1672-3. PubMed ID: 22988727
[TBL] [Abstract][Full Text] [Related]
15. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of fecal calprotectin concentration as inflammatory marker in inflammatory bowel diseases in children--preliminary report].
Krzesiek E; Iwańczak B
Pol Merkur Lekarski; 2010 Oct; 29(172):241-6. PubMed ID: 21207640
[TBL] [Abstract][Full Text] [Related]
17. Relationship between fecal lactoferrin and inflammatory bowel disease.
Dai J; Liu WZ; Zhao YP; Hu YB; Ge ZZ
Scand J Gastroenterol; 2007 Dec; 42(12):1440-4. PubMed ID: 17852860
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
Schröder O; Naumann M; Shastri Y; Povse N; Stein J
Aliment Pharmacol Ther; 2007 Oct; 26(7):1035-42. PubMed ID: 17877510
[TBL] [Abstract][Full Text] [Related]
19. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].
van den Bergh FA; Kolkman JJ; Russel MG; Vlaskamp RT; Vermes I
Ned Tijdschr Geneeskd; 2003 Nov; 147(48):2360-5. PubMed ID: 14677476
[TBL] [Abstract][Full Text] [Related]
20. Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease.
Lundberg JO; Hellström PM; Fagerhol MK; Weitzberg E; Roseth AG
Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):96-102. PubMed ID: 16265127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
